# Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/ABSI/absci-to-participate-in-the-25th-annual-needham-virtual-healthcare-conference
Ticker: ABSI
Company: Absci Corporation
Source: Absci Corporation
Published: 2026-04-08 12:00 EST
Original Source URL: https://investors.absci.com
## Summary

VANCOUVER, Wash. and NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will be participating in the upcoming 25 th Annual Needham

## Article Body
VANCOUVER, Wash. and NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will be participating in the upcoming 25 th Annual Needham
## Recent Company News
- 2026-05-07 20:06 EST — [Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results](https://biopharmsignal.com/news/ABSI/absci-reports-business-updates-and-first-quarter-2026-financial-and-operating-results) — Source: Absci Corporation
- 2026-05-05 00:12 EST — [Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/ABSI/absci-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4) — Source: Absci Corporation
- 2026-04-23 20:04 EST — [Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026](https://biopharmsignal.com/news/ABSI/absci-to-report-business-updates-and-first-quarter-2026-financial-and-operating-results-on-may-7-2026) — Source: Absci Corporation
- 2026-04-08 12:00 EST — [Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference](https://biopharmsignal.com/news/ABSI/absci-to-participate-in-the-25th-annual-needham-virtual-healthcare-conference) — Source: Absci Corporation
- 2026-03-24 20:05 EST — [Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results](https://biopharmsignal.com/news/ABSI/absci-reports-business-updates-and-fourth-quarter-and-full-year-2025-financial-and-operating-results) — Source: Absci Corporation
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)